Synta Pharmaceuticals Corp. (NASDAQ: SNTA) today announced that the Company will present at the following September investor conferences:
Rodman & Renshaw Annual Global Investment Conference in New YorkMonday, September 10 at 1:35 p.m. (ET)
ThinkEquity’s 9th Annual Growth Conference in New YorkWednesday, September 12 at 3:30 p.m. (ET)
UBS Global Life Sciences Conference in New YorkThursday, September 20, 2012 at 3:30 p.m. (ET)Noble Financial Markets Life Sciences Exposition in Stamford, CTMonday, September 24, 2012 at 1:00 p.m. (ET) Live audio webcasts and replays of these presentations will be available on the "Investors" section of the Company's website, www.syntapharma.com. About Synta Pharmaceuticals Synta Pharmaceuticals Corp. is a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to extend and enhance the lives of patients with severe medical conditions, including cancer and chronic inflammatory diseases. Synta has a unique chemical compound library, an integrated discovery engine, and a diverse pipeline of clinical- and preclinical-stage drug candidates with distinct mechanisms of action and novel chemical structures. All Synta drug candidates were invented by Synta scientists using our compound library and discovery capabilities. For more information, please visit www.syntapharma.com.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts